Is there a future for maintenance temozolomide chemotherapy in PCNSL?

Neuro Oncol. 2023 Apr 6;25(4):699-700. doi: 10.1093/neuonc/noad015.

Authors

Jacoline E C Bromberg¹, Jeanette K Doorduijn²

Affiliations

¹ Department of Neuro-Oncology, Erasmus MC University Medical Center Cancer Institute, Rotterdam, the Netherlands.
² Department of Hematology, Erasmus MC University Medical Center Cancer Institute, Rotterdam, The Netherlands.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Brain
Dacarbazine / therapeutic use
Humans
Lymphoma*
Methotrexate* / administration & dosage
Temozolomide / therapeutic use

Substances

Temozolomide
Methotrexate
Dacarbazine